Summary: Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, returns to discuss crucial considerations for reopening the country, reactions to the way infection control experts have handled new information, and the overreaction to a recent preliminary report from the University of Chicago on a potential treatment option.
